Evidence map›Paper›PMID 39356939›Full record

ArticleEinstein (Sao Paulo, Brazil)2024

Fatality from COVID-19 does not affect palliative care duration among patients with advanced cancer: a retrospective cohort study.

Rafael Tavares Jomar, Jéssica Thaís Nascimento Marques, Livia Costa de Oliveira, Gelcio Luiz Quintella Mendes, Daianny Arrais de Oliveira da Cunha, Raphael Mendonça Guimarães

Abstract read
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rafael Tavares JomarInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-4101-7138
Jéssica Thaís Nascimento MarquesInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-5819-5395
Livia Costa de OliveiraInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-5052-1846
Gelcio Luiz Quintella MendesInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-9564-0892
Daianny Arrais de Oliveira da CunhaInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0003-2109-319X
Raphael Mendonça GuimarãesEscola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0003-1225-6719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJomar et al. demonstrated that death due to COVID-19 did not affect the time under exclusive palliative care among patients with advanced cancer, even during the first year of the pandemic caused by a hitherto little-known disease.

background◼ Fatality due to COVID-19 does not alter the time under oncological palliative care.

background◼ The retrospective design of this pioneering study allows causal inference.

background◼ Access to oncological palliative care frequently approaches terminality of life.

objectiveThis study aimed at investigating the extent to which COVID-19-induced fatalities affect the duration of palliative care among patients with advanced cancer.

methodsA retrospective cohort study was conducted at the Palliative Care Unit of the Brazilian Instituto Nacional de Câncer in Rio de Janeiro, Brazil, on 1,104 advanced cancer patients who died under exclusive palliative care between March 11, 2020, and March 31, 2021. Wilcoxon rank-sum (Mann-Whitney U) and log-rank tests were performed to examine statistical differences between the medians of time, and the Kaplan-Meier estimator was used to graphically illustrate survival over time under exclusive palliative care contingent upon the underlying causes of death of the two experimental groups (cancer versus COVID-19).

resultsA total of 133 (12.05%) patients succumbed to COVID-19. In both groups, the median time under exclusive palliative care was less than one month. The exclusive palliative care survival curves did not exhibit any statistically significant difference between the groups.

conclusionDeath due to COVID-19 did not modify the duration of exclusive palliative care among patients with advanced cancer.

Indexed as

COVID-19NeoplasmsPalliative CareAdultAgedAged, 80 and overBrazilCohort StudiesFemaleHumansMaleMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2Time Factors

Identifiers

PMID39356939
PMCPMC11461002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.